Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: A cross-over study

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 4, 1996, Pages 591-594

  Droste, Dirk W ^a,b   Siemens, Hans J ^a   Sonne, Miriam ^a   Kaps, Manfred ^a   Wagner, Thomas ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Aspirin; Platelet aggregability; Platelets; Ticlopidine

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; COLLAGEN; FIBRINOGEN; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEMOSTASIS; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

ADENOSINE DIPHOSPHATE; AGED; ASPIRIN; CEREBROVASCULAR DISORDERS; COLLAGEN; CROSS-OVER STUDIES; EPINEPHRINE; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET COUNT; PROSPECTIVE STUDIES; TICLOPIDINE;

EID: 0029759703     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199610000-00018     Document Type: Article

References (13)

1. Hass WK, Easton JD, Adams HP, Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989;321:501-7.
2. Weksler BB, Pett SB, Alonso B, et al. Differential inhibition by aspirin of vascular and platelet prostaglandin synthesis in atherosclerotic patients. N Engl J Med 1983;308:800-5.
3. Coller B. Platelets and thrombolytic therapy. N Engl J Med 1990;322:33-42.
4. McTavish D, Faulds D, Goa KL. Ticlopidine: an updated review. Drugs 1990;40:238-59.
5. Berglund U, von Schenck H, Wallentin L. Effects of ticlopidine on platelet function in men with stable angina pectoris. Thromb Haemost 1985;54:808-12.
6. Knudsen JB, Kjoller E, Skagen K, Gormsen J. The effect of ticlopidine on platelet functions in acute myocardial infarction. Thromb Haemost 1985;53:332-6.
7. Maffrand JP, Bernat A, Delebassée D, Defreyn G, Cazenave JP, Gordon JL. ADP plays a key role in thrombogenesis in rats. Thromb Haemost 1980;59:225-30.
8. Cattaneo M, Akkawat B, Lecchi A, Ciminiello C, Capitanio AM, Mannucci PM. Ticlopidine selectively inhibits human platelet responses to adenosine diphosphate. Thromb Haemost 1991;66:694-9.
9. Tohgi H, Takahashi H, Kashiwaya M, Watanabe K. Effect of plasma fibrinogen concentration on the inhibition of platelet aggregation after ticlopidine compared with aspirin. Stroke 1994;25:2017-21.
10. Tohgi H, Tamura K, Kimura B, Kimura M, Suzuki H. Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin. Stroke 1988;19:700-3.
11. Randi ML, Fabris F, Crociana ME, Battocchio F, Girolami A. Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease. Arzneimittelforschung 1985;35:1847-9.
12. Boudreaux MK, Jeffers C, Lipscomb D, Spano JS. The effect of ticlopidine on canine platelets, fibrinogen. and antithrombin. J Vet Pharmacol Ther 1992;15:1-9.
13. Wilkinson AR, Hawker RJ, Hawker LM. The influence of antiplatelet drugs on platelet survival after aortic damage or implantation of a dacron arterial prosthesis. Thromb Res 1979;15:181-9.